Teva Pharmaceutical Industries Limited

TEVANYSEHealthcareDrug Manufacturers - Specialty & Generic

$39.95- (-)1Y +111.41%

As of Oct 26, 2026 close

Market cap: $46.54B
P/E (TTM): 64.92
Forward P/E: -
Dividend yield: -
52-week range: $18.83$42.02
Volume (live): -
Avg. volume (3M): 5.94M

Teva Pharmaceutical Industries Limited (TEVA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Teva Pharmaceutical Industries Limited stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(15 total ratings in last 90 days)

High Confidence9.0:1 Buy/Sell

Average Price Target

$48.39

+21.13% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest TEVA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 16, 2026	Glen Santangelo	Barclays	Maintains	Buy	$47.00
Oct 13, 2026	Sabina Levi	Leader Capital	Maintains	Buy	$49.55
Oct 13, 2026	Louise Chen	Scotiabank	Maintains	Buy	$47.00
Oct 13, 2026	Glen Santangelo	Barclays	Maintains	Buy	$42.00
Oct 13, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Sell	-
Oct 12, 2026	Salveen Richter	Goldman Sachs	Maintains	Buy	$50.00
Oct 11, 2026	Chris Schott	JP Morgan	Maintains	Buy	$40.00 → $50.00 +10.00 (+25.0%)
Oct 9, 2026	Jason Gerberry	BofA Securities	Reiterates	Buy	$43.00
Oct 2, 2026	Louise Chen	Scotiabank	Maintains	Buy	$47.00
Oct 1, 2026	David Amsellem	Piper Sandler	Reiterates	Buy	$44.00
Oct 1, 2026	Joseph Thome	TD Cowen	Initiates	Buy	$55.00
Sep 24, 2026	Jason Gerberry	BofA Securities	Maintains	Buy	$43.00
Sep 24, 2026	Chris Schott	JP Morgan	Maintains	Buy	-
Sep 23, 2026	Unknown Analyst	Oppenheimer	Initiates	Buy	$50.00
Aug 11, 2026	Glen Santangelo	Barclays	Maintains	Buy	$42.00

Glen Santangelo

Barclays

BuyMaintains

$47.00

Oct 16

Sabina Levi

Leader Capital

BuyMaintains

$49.55

Oct 13

Louise Chen

Scotiabank

BuyMaintains

$47.00

Oct 13

Glen Santangelo

Barclays

BuyMaintains

$42.00

Oct 13

Zacks Equity Research

SellInitiates Coverage

Oct 13

Salveen Richter

Goldman Sachs

BuyMaintains

$50.00

Oct 12

Chris Schott

JP Morgan

BuyMaintains

$40.00 → $50.00

Oct 11

Jason Gerberry

BofA Securities

BuyReiterates

$43.00

Oct 9

Louise Chen

Scotiabank

BuyMaintains

$47.00

Oct 2

David Amsellem

Piper Sandler

BuyReiterates

$44.00

Oct 1

Joseph Thome

TD Cowen

BuyInitiates

$55.00

Oct 1

Jason Gerberry

BofA Securities

BuyMaintains

$43.00

Sep 24

Chris Schott

JP Morgan

BuyMaintains

Sep 24

Unknown Analyst

Oppenheimer

BuyInitiates

$50.00

Sep 23

Glen Santangelo

Barclays

BuyMaintains

$42.00

Aug 11

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for TEVA?

The analyst consensus rating for TEVA is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for TEVA?

The average 12-month price target for TEVA is $48.39, representing an upside of 21.1% from the Oct 26, 2026 close of $39.95.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.